Skip to content
value.today
SutroVax, Inc. logo

SutroVax, Inc.

Total raised
$206 M
4 rounds on record
Latest round
$110 M
Mar 2020
First round on record
Jul 2015
Today
Went public
See the company page

SutroVax, Inc. is listed today as Vaxcyte, Inc.: market value, financials and filings are on its company page.

Funding rounds

4 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of SutroVax, Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Mar 2020$110 MNo. 4$50 to $250 million

SutroVax, Inc.: Raise no. 4, Mar 2020

Investors in this round

23 investors had bought by the notice of Apr 3, 2020: 23 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 4 investors are named for SutroVax, Inc. as a whole in other filings: see Investors below.

What the notice says

Amount sold
$110 M of $110 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Grant E Pickering · Executive Officer, Director
  • James P Wassil · Executive Officer
  • Jane P Wright-Mitchell · Executive Officer
  • Jeff E Fairman · Executive Officer
  • Heath J Lukatch · Director
  • Kurt P von Emster · Director
  • Moncef J Slaoui · Director
  • Patrick J Enright · Director
  • Patrick J Heron · Director
  • Peter J Hirth · Director
  • Rob J Hopfner · Director
  • William J Newell · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Grant Pickering, Ceo. Source: SEC Form D, newest notice filed Apr 3, 2020. Read the notice at the SEC.

equitySEC
May 2018$43 MNo. 3$10 to $50 million

SutroVax, Inc.: Raise no. 3, May 2018

Investors in this round

12 investors had bought by the notice of Jun 12, 2018: 12 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 4 investors are named for SutroVax, Inc. as a whole in other filings: see Investors below.

What the notice says

Amount sold
$43 M of $86 M offered; $43 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity, options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Durga P Bobba · Executive Officer
  • Elaine P Sun · Executive Officer
  • Grant E Pickering · Executive Officer, Director
  • Jeff E Fairman · Executive Officer
  • Heath J Lukatch · Director
  • Kurt P von Emster · Director
  • Moncef J Slaoui · Director
  • Patrick P Enright · Director
  • Patrick P Heron · Director
  • Peter J Hirth · Director
  • Rob J Hopfner · Director
  • William J Newell · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Elaine Sun, Cfo. Source: SEC Form D, newest notice filed Jun 12, 2018. Read the notice at the SEC.

equity, optionsSEC
Mar 2017$40 MNo. 2$10 to $50 million

SutroVax, Inc.: Raise no. 2, Mar 2017

Investors in this round

9 investors had bought by the notice of Mar 21, 2017: 9 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 4 investors are named for SutroVax, Inc. as a whole in other filings: see Investors below.

What the notice says

Amount sold
$40 M of $60 M offered; $20 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Ashish Khanna · Executive Officer
  • Elaine Sun · Executive Officer
  • Grant Pickering · Executive Officer, Director
  • Jeff Fairman · Executive Officer
  • Kurt von Emster · Director
  • Patrick Enright · Director
  • Patrick Heron · Director
  • Peter Hirth · Director
  • Tracy Saxton · Director
  • William Newell · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Grant Pickering, Ceo. Source: SEC Form D, newest notice filed Mar 21, 2017. Read the notice at the SEC.

equitySEC
Jul 2015$13 MNo. 1$10 to $50 million

SutroVax, Inc.: Raise no. 1, Jul 2015

Investors in this round

7 investors had bought by the notice of Jul 24, 2015: 7 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 4 investors are named for SutroVax, Inc. as a whole in other filings: see Investors below.

What the notice says

Amount sold
$13 M of $27 M offered; $14 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity, securities to be acquired by exercising them
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Ashish E Khanna · Executive Officer
  • Grant E Pickering · Executive Officer, Director, Promoter
  • Jeff E Fairman · Executive Officer
  • Kurt E von Emster · Director
  • Patrick E Enright · Director
  • Tracy E Saxton · Director
  • William E Newell · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Ashish Khanna, Chief Business Officer. Source: SEC Form D, newest notice filed Jul 24, 2015. Read the notice at the SEC.

equitySEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • SutroVax, Inc. chose not to state its revenue in its newest notice of a funding round (Apr 2020).

    SEC Form D · Apr 2020

  • The industry group it chose in its notices: Biotechnology.

    SEC Form D · Apr 2020

That is all the official record says: SutroVax, Inc. has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.

Products and services#

No products or services of SutroVax, Inc. are on record.

Investors#

4 named in official filings. Open an investor to see everything it has backed.

Investors in SutroVax, Inc.
InvestorKindAmountRoundRoleSource
Abingworth LLPFund or asset managernot statednot statedHeld Series A, B, C and D preferred stock, 10% owner (Form 3, 2020)SEC Form 3
Longitude Capital Partners II, LLCFund or asset managernot statednot statedHeld Series A, B, C and D preferred stock, 10% owner (Form 3, 2020)SEC Form 3
Longitude Venture Partners II, L.P.Venture capitalnot statednot statedHeld Series A, B, C and D preferred stock, 10% owner (Form 3, 2020)SEC Form 3
TPG Group Holdings (SBS) Advisors, Inc.Fund or asset managernot statednot statedHeld Series C and D preferred stock, 10% owner (Form 3, 2020)SEC Form 3

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 4 rounds above had up to 23 investors.

Largest shareholders today

Institutions holding Vaxcyte, Inc. shares, as of Sep 30, 2026.

Source: SEC Form 13F holdings reports · as of Sep 30, 2026. Value held and share of the company. All holders are on the company page.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by SutroVax, Inc.
NameRoleNamed in
Grant E PickeringExecutive officerApr 2020
James P WassilExecutive officerApr 2020
Jane P Wright-MitchellExecutive officerApr 2020
Jeff E FairmanExecutive officerApr 2020
Durga P BobbaExecutive officerJun 2018
Elaine P SunExecutive officerJun 2018
Ashish KhannaExecutive officerMar 2017
Elaine SunExecutive officerMar 2017
Grant PickeringExecutive officerMar 2017
Jeff FairmanExecutive officerMar 2017
Ashish E KhannaExecutive officerJul 2015
Grant E PickeringDirectorApr 2020
Heath J LukatchDirectorApr 2020
Kurt P von EmsterDirectorApr 2020
Moncef J SlaouiDirectorApr 2020
Patrick J EnrightDirectorApr 2020
Patrick J HeronDirectorApr 2020
Peter J HirthDirectorApr 2020
Rob J HopfnerDirectorApr 2020
William J NewellDirectorApr 2020
Patrick P EnrightDirectorJun 2018
Patrick P HeronDirectorJun 2018
Grant PickeringDirectorMar 2017
Kurt von EmsterDirectorMar 2017
Patrick EnrightDirectorMar 2017
Patrick HeronDirectorMar 2017
Peter HirthDirectorMar 2017
Tracy SaxtonDirectorMar 2017
William NewellDirectorMar 2017
Kurt E von EmsterDirectorJul 2015
Patrick E EnrightDirectorJul 2015
Tracy E SaxtonDirectorJul 2015
William E NewellDirectorJul 2015
Grant E PickeringPromoterJul 2015

Went public since 2020. Its SEC number is that of a company listed on a stock exchange.